Stockreport

Lantern Pharma to Report Fourth Quarter and Fiscal Year 2023 Operating & Financial Results on March 18th, 2024 at 4:30 p.m. ET [Yahoo! Finance]

Lantern Pharma Inc.  (LTRN) 
PDF DALLAS, March 11, 2024 BUSINESS WIRE )--Lantern Pharma Inc. (NASDAQ: LTRN ), an artificial intelligence ("AI") company developing targeted and transformative cancer the [Read more]